博安生物(06955)：山东绿叶制药拟向Luye Geneora Holding进一步转让公司3850万股H股

Core Viewpoint - The company Boan Biotechnology (06955) announced that its board has been informed by its controlling shareholder, Luye Pharmaceutical Group, regarding a proposed transfer of 38.5 million H-shares by its wholly-owned subsidiary, Shandong Luye Pharmaceutical Co., Ltd., to the issuer Luye Geneora Holding Limited on January 22, 2026 [1] Group 1 - The controlling shareholder, Luye Pharmaceutical Group, is involved in a share transfer agreement related to exchangeable preferred shares [1] - The proposed transfer involves a significant number of shares, specifically 38.5 million H-shares [1] - The transaction is scheduled to take place on January 22, 2026 [1]